O uso do canabidiol no auxílio de doenças anticonvulsivantes e sua comercialização na indústria farmacológic

Abstract

This work presents Cannabidiol, an isolate of the Cannabis sativa plant, is its use as medicine, which will address the difficulties of obtaining this drug, your adverse events, therapeutic evaluation and some results obtained with its insertion into the antiepileptic regimens. It also discusses the possible benefits of using cannabidiol (CBD) in relation to some anticonvulsant diseases, mainly epilepsy, showing the possibilities of this substance through the understanding of the functioning of this drug. The study was exploratory through consultations to scientific articles selected in databases such as Scielo, NCBI, Elsevier, Scopus, PubMed, as well as books, national and international journals and institutional websites. Articles were selected in three languages: English, Spanish and Portuguese. Although the number of publications about Canabidiol is gradually expanding, there are still controversies in its use, one of them confirming its pharmacological use other than that it has no dangerous side effects like the possibility acting in our brain, changing our psyche, limiting to the use. Therefore, more research are needed with a larger number of people to confirm the effectiveness of the drug in order to deconstruct an existing pre-judgment because its origin is related to the extraction of the Cannabis sativa plant.